PB2083: STUDY CONDUCT AND PATIENT SAFETY DURING THE COVID-19 PANDEMIC: OBSERVATIONS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA FROM THE GAZELLE TRIAL OF OBINUTUZUMAB SHORT DURATION INFUSION

• M. A. Canales,
• T. A. Buchholz,
• T. Ishikawa,
• L. M. Fogliatto,
• J. Bortolini,
• F. J. Capote Huelva,
• A. Salar,
• D. Tucker,
• E. Vorozheikina,
• D. Klingbiel,
• S. Pokala,
• J. Parreira,
• S. Nick,
• K. Hübel

Affiliations

M. A. Canales

1 Hospital Universitario La Paz, Madrid, Spain

T. A. Buchholz

2 Scripps MD Anderson Cancer Center, San Diego, United States of America

T. Ishikawa

3 Kobe City Medical Center, General Hospital, Hyogo, Japan

L. M. Fogliatto

4 Hospital de Clínicas de Porto Alegre, Porto Alegre

J. Bortolini

5 Centro de Pesquisas Oncologicas, Florianopolis, Brazil

F. J. Capote Huelva

6 Hospital Universitario Puerta del Mar, Cádiz

A. Salar

7 Hospital del Mar, Barcelona, Spain

D. Tucker

8 Royal Cornwall NHS Trust, Truro, Cornwall, United Kingdom

E. Vorozheikina

9 IQVIA, Medical and Scientific Services, Moscow, Russia

D. Klingbiel

10 F. Hoffmann-La Roche Ltd, Basel, Switzerland

S. Pokala

10 F. Hoffmann-La Roche Ltd, Basel, Switzerland

J. Parreira

10 F. Hoffmann-La Roche Ltd, Basel, Switzerland

S. Nick

10 F. Hoffmann-La Roche Ltd, Basel, Switzerland

K. Hübel

11 Uniklinik Köln, Köln, Germany